IPO

Dipna Pharmachem Limited

BSE SME

Listed On: Sep 8, 2022 at ₹ 32.00

₹ 228000 /6000 Shares
*Min Investment

Check Allotment

25 Aug, 2022

Open Date

30 Aug, 2022

Close Date

05 Sep, 2022

Allotment Date

08 Sep, 2022

Listing Date
IPO Issue Details
  • Issue Price ₹38 per equity share
  • Face Value ₹10 Per Equity Share
  • Issue Price 4,002,000 shares of ₹10(aggregating up to ₹15.21 Cr)
  • Listing at BSE SME
  • List Price 32.00
  • Listing Date 2022-09-08
  • Lead Manager Interactive Financial Services Ltd
  • Registrar Bigshare Services Pvt Ltd
IPO Details
  • Retail Portion N/A
IPO Documents
IPO Details


Dipna Pharmachem Limited is an SME IPO, priced at ₹38 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the BSE SME platform.

The IPO bidding window is open from Aug 25, 2022 to Aug 30, 2022. The allotment is expected to be finalized on Sep 5, 2022, and the tentative listing date is Sep 8, 2022.


The registrar of the IPO is Bigshare Services Pvt Ltd, and

Read More
IPO Subscription Analysis And Details
Retail
4.75x
Total
2.77x
As onQIB / NIIRetailTotal
Shares Offered / Reserved1,899,0001,899,0003,798,000
Day 1 25-08-22 06:00 PM
0.02 x0.29 x0.15 x
Day 2 26-08-22 06:00 PM
0.06 x1.09 x0.58 x
Day 3 29-08-22 06:00 PM
0.30 x2.27 x1.28 x
Day 4 30-08-22 06:00 PM
0.78 x4.75 x2.77 x
Valuations
Earnings Per Share (EPS) ₹333.40/-
P/E Ratio 0.11
RoNW 67.12%
Net Asset Value (NAV) ₹496.74/-
Company Financials
In Lakhs
In Lakh
31-Mar-2031-Mar-2131-Mar-22
Assets1844.182479.343622.96
Revenue3054.853101.547276.58
Profit After Tax5.92.42116.69
About Company

Incorporated in 2011, Dipna Pharmachem Limited is engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. The Company also started selling chemicals on a commission basis in the Financial year 2022. The company conducts business in Ahmedabad and the surrounding area of Ahmedabad.
The company's product portfolio comprises 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovascular, Anti - Bacteria, Quinolones, Veterinary, Anti - Virus, Anti - Inflammatory, Neuropsychiatry, Steroid Hormone, other etc.
The company is supplying raw materials to pharmaceutical industries and the pharmaceutical industry falls under the essential business list declared by the Government.

Read More
- Promoter(s)

Mr. Keyur Dipakkumar Shah

Pre Issue Share Holding : 100%

Post Issue Share Holding : 66.56%

IPO - Issue Objectives
1

Working capital requirement.

2

General corporate purposes.